Sex differences in psychotomimetic-induced behaviours in rats.
Andrea Gogos, Snezana Kusljic, Shane J Thwaites, Maarten Van den Buuse
Behavioural Brain Research March 30, 2017 DOI: 10.1016/j.bbr.2017.01.028 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal model study Peer reviewed |
|---|---|
| Population | Adult male and female Sprague-Dawley rats |
| Interventions | Amphetamine Phencyclidine |
| Duration | Acute |
| Keywords | Amphetamine Female Locomotor hyperactivity Phencyclidine Prepulse inhibition |
| Key points | Sensitivity to amphetamine, but not phencyclidine, differs between male and female rats, and this sex difference is selective to locomotor hyperactivity and startle, but not prepulse inhibition. |
Abstract
Animal model studies using equal numbers of males and females are sparse in psychiatry research. Given the marked sex differences observed in psychiatric disorders, such as schizophrenia, using both males and females in research studies is an important requirement. Thus the aim of this study was to examine sex differences in psychotomimetic-induced behavioural deficits relevant to psychosis. We therefore compared the acute effect of amphetamine or phencyclidine on locomotor activity and prepulse inhibition in adult male and female Sprague-Dawley rats. The results of this study were that: (1) amphetamine-induced distance travelled was greater in female rats than in male rats, (2) phencyclidine-induced locomotor hyperactivity was similar in male and female rats; (3) there were no sex differences in amphetamine- or phencyclidine-induced disruption of prepulse inhibition; (4) male rats had an increased startle response after amphetamine. These findings suggest that sensitivity to amphetamine, but not phencyclidine, differs between male and female rats, and that this sex difference is selective to locomotor hyperactivity and startle, but not prepulse inhibition. This study used two widely-used, validated preclinical assays relevant to psychosis; the results of this study have implications for psychiatry research, particularly for disorders where marked sex differences in onset and symptomology are observed.
Citations in the library
Cited by 2
- Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry July 5, 2025
- Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats. Journal of Integrative Neuroscience January 28, 2022
Cites 9
- Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 2000
- Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release Brain Research April 1, 1999
- Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA) Behavioural Pharmacology March 1, 2005
- Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation. Neuroscience June 16, 2010
- Phencyclidine (PCP) produces sexually dimorphic effects on voluntary sucrose consumption and elevated plus maze behavior. Pharmacology, Biochemistry, and Behavior April 2010
and 4 more in the library